New Key Statistics Module, Z-Score and F-Score
OTCPK:RPHCF Key Ratios
Market Cap $ M | 4,566.82 |
Enterprise Value $ M | 4,024.32 |
P/E(ttm) | 22.48 |
PE Ratio without NRI | 21.52 |
Forward PE Ratio | -- |
Price/Book | 2.89 |
Price/Sales | 2.64 |
Price/Free Cash Flow | 33.05 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -- |
Beneish M-Score | -2.35 |
10-y EBITDA Growth Rate % | 7.80 |
5-y EBITDA Growth Rate % | 13.60 |
y-y EBITDA Growth Rate % | 21.80 |
EV-to-EBIT | 14.93 |
EV-to-EBITDA | 14.93 |
PEG | 1.58 |
Shares Outstanding M | 228.14 |
Net Margin (%) | 11.72 |
Operating Margin % | 15.42 |
Pre-tax Margin (%) | 15.68 |
Quick Ratio | 1.98 |
Current Ratio | 2.56 |
ROA % (ttm) | 9.55 |
ROE % (ttm) | 13.91 |
ROIC % (ttm) | 13.87 |
Dividend Yield % | 0.88 |
Altman Z-Score | 6.79 |
RPHCF Number of Guru Trades
RPHCF Volume of Guru Trades
Gurus Latest Trades with OTCPK:RPHCF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:RPHCF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Rohto Pharmaceutical Co Ltd Insider Transactions
No Available Data
News about OTCPK:RPHCF
Total 0- 1